怡康医药YIKANG品牌怎么样 申请店铺

我要投票 怡康医药YIKANG在医疗器械行业中的票数:728 更新时间:2026-01-23
怡康医药YIKANG是哪个国家的品牌?「怡康医药YIKANG」是 西安怡康医药连锁有限责任公司 旗下著名品牌。该品牌发源于陕西省西安市,在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力怡康医药YIKANG品牌出海!将品牌入驻外推网,定制怡康医药YIKANG品牌推广信息,可以显著提高怡康医药YIKANG产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

怡康医药YIKANG怎么样

陕西怡康医药有限责任公司成立于2001年,目前拥有全资及控股公司14家,全省连锁葯店700余家,经营范围涵盖化学药制剂、抗生素、生化药品、生物制品、中成药、中药饮片、中药材、医疗器械、保健品、消毒用品等,经营品规10000多种。药品配送覆盖全省85%以上的地区,约107个县,企业员工6000余人,年度总销售额可达60亿元。

陕西怡康医药有限责任公司以医药经营为核心,业务覆盖了医药零售批发、医药物流、医药电商三大业务板块。批发销售网络覆盖省内各地市级医院及部队医院;市、县、乡镇,配送区域至:延安宝塔区、延长县、延川县、渭南市富平县、安康市汉滨区、西安市周至县、雁塔区等范围,并于2014年9月份成功入围宝鸡市高新区、扶风县、凤县“三统一”中标药品配送。经由2016年整合统计,陕西怡康医药现配送网络已覆盖各区县级及基层医疗机构,配送医疗机构约7000家,覆盖率100%,药品配送率达95%以上,累计销售逐年递增;公司配送中心库房总面积11000平方米,库房总面积11000平米,库存品规10000多个,拥有配送车辆近50辆,冷链车20辆。广阔的网络体系和信息化、自动化的运营体系,科学、合理、严谨的管理模式,以KSOA企业信息融通平台、WMS仓储管理、协同商务、U890用友财务、GPS定位系统、HR人力资源软件等现代化管理体系为业务、仓储、上下游客户、财务,物流、人力六大系统服务,使管理更加流程化、科学化。

2016年集团公司特斥资近2亿元倾力打造了总建筑面积5万余平米的“怡康医药集团物流中心”,集办公、物流配送及生活服务为一体,并按照新版GSP要求配备完善的温湿度、自动监控等基础设施;优良的电子分拣系统,大大提高了复核分拣效率,堪称现代医药企业办公中心典范;2014年开始布局医药电商。2015年7月7日“怡康到家”APP正式上线,标志着怡康医药从传统医药零售,迈入了以怡康到家自有平台和天猫、京东、百度等第三方平台相结合的立体化销售模式。


Shaanxi Yikang Pharmaceutical Co., Ltd. was founded in 2001. At present, it has 14 wholly-owned and holding companies and more than 700 chain drugstores in the province. Its business scope covers chemical pharmaceutical preparations, antibiotics, biochemical drugs, biological products, Chinese patent medicine, Chinese herbal medicines, medical devices, health care products, disinfection products, etc., with more than 10000 product specifications. Drug distribution covers more than 85% of the province, about 107 counties, with more than 6000 employees, and the total annual sales volume can reach 6 billion yuan. Shaanxi Yikang Pharmaceutical Co., Ltd. takes pharmaceutical business as the core, covering three business sectors: pharmaceutical retail and wholesale, pharmaceutical logistics and pharmaceutical e-commerce. The wholesale sales network covers all municipal hospitals and military hospitals in the province; cities, counties and towns, and the distribution areas are: Baota District, Yanchang County, Yanchuan County, Fuping County, Weinan City, Hanbin District, Ankang City, Zhouzhi County and Yanta District of Xi'an City, etc. in September 2014, it was successfully shortlisted for the "three unified" bid winning drug distribution in Baoji high tech Zone, Fufeng County and Fengxian County. According to the integrated statistics in 2016, the distribution network of Shaanxi Yikang Pharmaceutical Co., Ltd. now covers county-level and grass-roots medical institutions in all regions, with 7000 distribution medical institutions, 100% coverage, and more than 95% drug distribution rate, with the cumulative sales increasing year by year; the total area of the company's distribution center warehouse is 11000 square meters, with 11000 square meters, more than 10000 inventory specifications, nearly 50 distribution vehicles, and cold 20 chain cars. Wide network system, information and automation operation system, scientific, reasonable and rigorous management mode, and six systems of business, storage, upstream and downstream customers, finance, logistics and human resources, which are modern management systems such as ksoa enterprise information fusion platform, WMS storage management, collaborative business, u890 UFIDA finance, GPS positioning system, HR human resources software, etc., serve to make management more efficient Add process and scientific. In 2016, the group company invested nearly 200 million yuan to build the "Yikang Pharmaceutical Group Logistics Center" with a total building area of more than 50000 square meters, integrating office, logistics distribution and life services, and equipped with complete temperature and humidity, automatic monitoring and other infrastructure according to the requirements of the new GSP. The excellent electronic sorting system has greatly improved the efficiency of recheck sorting, which can be called the modern pharmaceutical enterprise office Model of public center; medical e-commerce began to be distributed in 2014. On July 7, 2015, "Yikang home" app was officially launched, marking that Yikang medicine has entered into a three-dimensional sales mode combining Yikang home's own platform with tmall, JD, Baidu and other third-party platforms from traditional medicine retail.

本文链接: https://brand.waitui.com/0bd2ddbd5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

2小时前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

2小时前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

2小时前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

2小时前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

2小时前

本页详细列出关于怡康医药YIKANG的品牌信息,含品牌所属公司介绍,怡康医药YIKANG所处行业的品牌地位及优势。
咨询